Corrigendum: ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity.
E6 E7 oncogene expression
ErbB2
HER2/neu
HPV16
human papillomavirus
promoter activity
tucatinib
tyrosine kinase inhibitor
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
13
02
2024
accepted:
19
02
2024
medline:
18
3
2024
pubmed:
18
3
2024
entrez:
18
3
2024
Statut:
epublish
Résumé
[This corrects the article DOI: 10.3389/fimmu.2024.1335302.].
Identifiants
pubmed: 38495882
doi: 10.3389/fimmu.2024.1385729
pmc: PMC10940864
doi:
Types de publication
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
1385729Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright © 2024 Mikuličić, Shamun, Massenberg, Franke, Freitag, Döring, Strunk, Tenzer, Lang and Florin.